Memorial Sloan-Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove small breast cancers.

Findings from a multidisciplinary research team led by Memorial Sloan-Kettering medical oncologist and immunologist Jedd Wolchok could help shed light on the immune system’s role in fighting cancer.

Many cancers that develop in the mouth, nose, throat, and larynx can be cured. Watch this series to learn how our experts collaborate to give patients the best chance of a positive outcome.

The director of the Spine Tumor Center explains how this new, high-powered approach to radiation therapy has changed the way spine tumors are treated at Memorial Sloan-Kettering.

The recent FDA approval of axitinib provides a viable treatment option for patients who progress on or cannot tolerate the side effects of other approved drugs for the disease.

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

While a diagnosis of cervical cancer once required a hysterectomy, a procedure called a radical trachelectomy eliminated Stephanie Luedke’s cancer and preserved her ability to bear a child.